Drug Shortage Report for MYLAN-HYDROXYUREA
| Report ID | 3372 |
| Drug Identification Number | 02242920 |
| Brand name | MYLAN-HYDROXYUREA |
| Common or Proper name | HYDROXYUREA |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROXYUREA |
| Strength(s) | 500MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100BT |
| ATC code | L01XX |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-07-21 |
| Actual start date | 2017-07-24 |
| Estimated end date | 2018-02-26 |
| Actual end date | 2018-02-27 |
| Shortage status | Resolved |
| Updated date | 2018-02-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2017-06-22 | English | Compare |
| v8 | 2017-06-22 | English | Compare |
| v7 | 2017-06-22 | English | Compare |
| v6 | 2017-06-22 | English | Compare |
| v5 | 2017-06-14 | English | Compare |
| v4 | 2017-05-04 | French | Compare |
| v3 | 2017-05-04 | English | Compare |
| v2 | 2017-03-17 | French | Compare |
| v1 | 2017-03-17 | English | Compare |